Lenvatinib mesylate - Bio-X ™

CAS : 857890-39-2

Ref. 3D-BL166696

Informations sur le produit

• Nom: Lenvatinib mesylate - Bio-X ™
• Marque: Biosynth
• Description: Lenvatinib is an anti-cancer drug that is a multi-kinase inhibitor for VEGFR1, VEGFR2 and VEGFR. It has been shown to be effective against several cancers such as thyroid cancer and is currently in clinical trials for the treatment of leukaemia and prostate cancer. Furthermore, Lenvatinib also inhibits the activity of other protein kinases, including those involved in inflammatory responses.

Propriétés chimiques

• Masse moléculaire: 522.96 g/mol
• Formule: C₂₂H₂₃ClN₄O₇S
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C21H19ClN4O4.CH4O3S/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11;1-5(2,3)4/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28);1H3,(H,2,3,4)
• Code InChI: InChIKey=HWLFIUUAYLEFCT-UHFFFAOYSA-N
• SMILES: COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O